(Q43740908)

26 November 2017

title

Rosuvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of myocardial periprocedural necrosis: the ROMA trial (English)

1 reference

26 November 2017

Gennaro Sardella

1

1 reference

26 November 2017

Giulia Conti

2

1 reference

26 November 2017

Michael Donahue

3

1 reference

26 November 2017

Massimo Mancone

4

1 reference

26 November 2017

Emanuele Canali

5

1 reference

26 November 2017

Carlotta De Carlo

6

1 reference

26 November 2017

Angelo Di Roma

7

1 reference

26 November 2017

Simone Calcagno

8

1 reference

26 November 2017

Luigi Lucisano

9

1 reference

26 November 2017

Francesco Fedele

10

1 reference

26 November 2017

publication date

8 November 2012

1 reference

Catheterization and Cardiovascular Interventions

26 November 2017

published in

1 reference

26 November 2017

volume

81

1 reference

26 November 2017

issue

1

1 reference

26 November 2017

page(s)

E36-43

1 reference

Myonecrosis after revascularization procedures

26 November 2017

cites work

1 reference

Myocardial infarction due to percutaneous coronary intervention

21 January 2018

1 reference

Death following creatine kinase-MB elevation after coronary intervention: identification of an early risk period: importance of creatine kinase-MB level, completeness of revascularization, ventricular function, and probable benefit of statin therapy

21 January 2018

1 reference

Prognostic implication of creatine kinase elevation following elective coronary artery interventions.

21 January 2018

1 reference

Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study.

21 January 2018

1 reference

Statin administration before percutaneous coronary intervention: impact on periprocedural myocardial infarction

21 January 2018

1 reference

Universal definition of myocardial infarction

21 January 2018

1 reference

Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation

21 January 2018

1 reference

Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary intervention

21 January 2018

1 reference

With the "universal definition," measurement of creatine kinase-myocardial band rather than troponin allows more accurate diagnosis of periprocedural necrosis and infarction after coronary intervention.

21 January 2018

1 reference

Antiatherothrombotic properties of statins: implications for cardiovascular event reduction

21 January 2018

1 reference

Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial

21 January 2018

1 reference

Effect of previous treatment with statins on outcome of patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention

21 January 2018

1 reference

Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial.

21 January 2018

1 reference

Novel approaches for preventing or limiting events (Naples) II trial: impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/CCD.24403

1 reference

26 November 2017

1 reference